sarpogrelate has been researched along with Chronic Kidney Failure in 1 studies
sarpogrelate: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hidaka, S | 1 |
| Kobayashi, S | 1 |
| Iwagami, M | 1 |
| Isshiki, R | 1 |
| Tsutsumi, D | 1 |
| Mochida, Y | 1 |
| Ishioka, K | 1 |
| Oka, M | 1 |
| Maesato, K | 1 |
| Moriya, H | 1 |
| Ohtake, T | 1 |
1 trial available for sarpogrelate and Chronic Kidney Failure
| Article | Year |
|---|---|
Sarpogrelate hydrochloride, a selective 5-HT(2A) receptor antagonist, improves skin perfusion pressure of the lower extremities in hemodialysis patients with peripheral arterial disease.
Topics: Aged; Blood Pressure; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Lower Extremity; M | 2013 |